Try our Advanced Search for more refined results
Health - July, 2010
224 articles
- GSK 'Triple Protection' Trademark Too Generic: Colgate
- FDA Links Cubicin To Serious Strain Of Pneumonia
- Study Finds Avandia, Actos Linked To Fractures
- Sandoz Drops Generic Mirapex Plans For Now
- Jury Clears Fresenius In Baxter Dialysis Patent Suit
- Fed. Circ. Won't Rehear Prandin Use Code Patent Case
- Sen. Panel Advances Ban On Pay-For-Delay Deals
- Plaintiffs Lose Class Cert. Bid in Mo. Neurontin Case
- FDA Uncovers Violations At Sanofi Vaccine Plant
- Judge OKs Smith & Nephew Letters About Patent Suit
- Weil Gotshal Reps THL In Intermedix Deal
- Overhauling The Associate Recruiting System
- Fed. Circ. Tosses Becton's $58M Syringe Patent Win
- Ala. Insurer Loses Bid To Query SC Court On 'Charges'
- Monsanto, Pfizer Move PCB Action To Federal Court
- House Bill Seeks FLSA Protections For Caregivers
- Australia Clears Novartis' Alcon Buy With Conditions
- FDA's Drug Ad Rule And Learned Intermediary Doctrine
- Cephalon, Mylan Drop Patents From Nuvigil Dispute
- Bracco Settles XL Suit Over Coverage Of False Ad Spat
- Paul Weiss Reps AMN In $220M Medfinders Deal
- Botched Plea Leads To Retrial In Zoloft Murder Case
- Nova Contract Claims Nixed In Glucose Monitor IP Suit
- College Fails To Get More Royalties From Merck Drug
- Investors Resurrect Fraud Suit Over Nixed Sanofi Drug
- Double-Patenting Dooms Lilly's Gemzar IP: Fed. Circ.
- Wyeth Wins Round 2 In Trio Of Fen-Phen Suits
- Kirkland Reps Vestar in $294M Deal for HealthGrades
- Bausch & Lomb Recalls Eye Vitamins Over Gel Design
- 'ObamaCare' And The ABCs Of 'Grandfathered' Plans
- Federal Law Applies In Cordis Stent Case: NJ Court
- NJ Law To Apply In Malicious Prosecution Suit V. Biovail
- St. Jude Goes After Volcano Over Guide Wire Patents
- Genzyme Sues Roxane Again Over Generic Hectorol
- Opportunities In Health Care Provider Transactions
- Stanford Receiver Sues Merge Healthcare For $9M
- Avandia Panelist Issue Sent To HHS Inspector General
- FTC Gaining High Ground In Pay-For-Delay Fight: Chair
- Dewey & LeBoeuf IP Trio Head To Kaye Scholer
- Orion, Sun Settle Patent Spat Over Parkinson's Drugs
- Humana Escapes Race Bias Class Action
- Sanofi Loses Suit Against FDA Over Generic Eloxatin
- Daw, Otto Bock Settle Prosthetic Knee Antitrust Spat
- FTC Thinks Rules Don't Apply To It: Watson CEO
- Khazanah Outbids Fortis In $2.6B Hospital Chain Offer
- FCC, FDA Team Up On Wireless Medical Device Rules
- Servier Gave False Info During Pharma Probe: EU
- Wyeth Bests Pa. Fen-Phen Hypertension Suit
- MDL Over Pfizer's Neurontin Soon To Be 46 Cases Lighter
- Qui Tam Plaintiff's Claims Against Forest Labs Survive
- Purdue, King End Spat Over Less Addictive Painkillers
- Sunrise, Former Execs Strike Deal In SEC Fraud Case
- Limiting Pass-On Defense In Calif. — With Exceptions
- Mylan Hit With Patent Suit Over FazaClo ANDA
- FDA Panel Rejects Plan To Curb Opioid Abuse
- FOIA Request Shows GSK Touted Off-Label Avodart Use
- Exergen Escapes False Marking Suit Due To Overlap
- How To Gain An Edge When Bringing A Daubert Motion
- Plaintiffs Atty Appeals Ban From AWP Cases
- Medicis, Mylan Settle Suits Over Acne Drug
- Boston Scientific Warns Of More Defibrillator Problems
- Senate Strips Pay-For-Delay Ban From Spending Bill
- To Compete Or Regulate: What's Right For Health Care?
- FTC Denies Violations In Watson Pay-To-Delay Probe
- Unite Here Gets $17M Verdict Nixed In Defamation Suit
- Forest, Merz Wrap Up Namenda Patent Litigation
- Novartis Offers EU Antitrust Fixes For Alcon Merger
- GAO Blasts Gene Test Cos. For Misleading Marketing
- Investors' Fraud Suit Against ArthroCare Trimmed
- EU Regulatory Procedures In The Pharmaceutical Sector
- NY Hospitals Lose Bid To Toss Nurses' Antitrust Claims
- Boehringer Hit With New OT Action Over Sales Reps
- Cisco, KV Targeted In False Marking Suits
- Lannett Sues Over FDA Morphine Warning Letter
- FDA Panel Favors Nixing Avastin For Breast Cancer
- Aetna Loses Bid To Intervene In Wellbutrin Suit
- FDA Warns Abbott Unit Over Glucose Monitors
- Alcon Recalls Constellation Eye Surgery System
- FDA Bars New Patients From Avandia Study
- Claims Cut From Suit In Hydroxycut Marketing MDL
- Suits Pile Up In Zimmer Hip Device MDL
- Rockefeller Fights Medical-Loss Ratio Loopholes
- AntiCancer, CRI Settle Cancer Tracker Patent Suits
- Unavoidable Truths Of Health Care Reform
- Pfizer Gets Off-Label Suit Over 12 Drugs Tossed
- 7th Circ. Revives Nurse's Race Bias Suit
- Teva Agrees To End IP Suit Over Aricept Patent
- AMA, Others Sue To Preserve Claims Against Wellpoint
- Public Health Groups Fight USTR Special 301 Program
- McDermott Accused Of $143M Patent App Blunder
- WARN Claims Sunk In SEIU's Hospital Layoff Spat
- Alpharma Sales Reps Exempt From OT: Judge
- Pro-Avandia FDA Panelist Is Paid GSK Speaker
- Philips, Biomet Accused Of False Patent Marking
- EHR Technology Certification: The Final Rule
- Fla. Hospital System Hit With Meal Break Suit
- J&J Hit With Grand Jury Subpoena Over Drug Recalls
- 5th Circ. Shoots Down Challenge To Vioxx Settlement
- Sullivan Reps Healthscope In $2.3B Buyout Offer
- Novartis Wins Punitive Damages Ruling In Aredia Suits
- FDA Finds Violations At Pa. J&J Plant
- Pfizer, Abbott, Others Hit With False Marking Suits
- Valeant Hit With Shareholder Suit Over $3B Biovail Deal
- Validity Of Pfizer's Protonix Patent Upheld
- Neutrogena False Ad Ruling Sticks In Sunscreen Spat
- J&J Gets SFF To Stop Selling Dodgy Glucose Strips
- Investor Accuses Amedisys Of Medicare Fraud
- Understanding 'In Loco Parentis' After DOL Clarification
- Court Spares Part Of Kickback Suit Against Abbott
- Teva, Novartis End Patent Spat Over Zometa
- Bayer Sues To Halt Lupin From Making Generic Yaz
- Plaintiffs Want Rader Recusal In Gene Patent Case
- Patent Claims Ruling For Wyeth Sticks In Effexor Suit
- CORRECTED: 35 Plaintiffs Cut In Pittsburgh Hospital Pay Policy Suit
- Medical Developer Sues RSUI Over $12.5M Settlement
- Sonnenschein Woos LeClairRyan IP Litigation Head
- King Pharma Sues Sandoz Over Generic EpiPen
- Elan Inks $204M Deal In Zonegran Off-Label Probe
- Is Burying A Material Reference Inequitable Conduct?
- Insurers Need Not Cover Avent's BPA Claims: 7th Circ.
- Okla. Wants In On Wyeth Protonix Medicaid Suits
- Settlement Reached In MetLife Unit's Fraud Suit
- Genzyme Sues Lupin Over Generic Renvela Powder
- Gilead Targets Lupin Over Generic Ranexa
- Taro Pharma's Suit To Block Sun Takeover Tossed
- GSK Ponied Up $2.4B In Legal Charges In 2nd Quarter
- Lawyers Push For Top Spots In Avandia MDL
- Latham Reps Carlyle Group In $3.8B NBTY Acquisition
- Iovate To Pay FTC $5.5M In False Health Claims Suit
- Cravath Reps Mylan In $550M Bioniche Purchase
- GSK Settles 10,000 Avandia Cases For $460M
- 12 Guidelines For Law Firm Marketing Investments
- Watson CEO OK'd To Quiz FTC In Subpoena Dustup
- Ex-HealthSouth CEO Seeks Early Release From Prison
- Cert. Denied, For Now, In Flonase Antitrust Suit
- Novartis Reps Strike $175M Deal To End Sex Bias Case
- Novo Hit With Another Monopoly Suit Over Prandin
- Mass. AG Escapes Sanctions In Medicaid Fraud Suit
- House Hearing Probes Drug Limits In Meat Farming
- FDA Panel Votes To Restrict GSK's Avandia
- SEC Eyes LHC Group, Gentiva Medicare Practices
- Insurers Accuse Arthrocare Of Medical Billing Fraud
- MicroAire, Arthrex Near Deal In Trade Secrets Suit
- Spotlight: M&A Trends In The Middle East
- Pfizer Faces Shareholder Suit Over $2.3B Settlement
- Abbott Settles Syringe Action Right Before Jury Verdict
- Novartis, Baxter Dismissed From Medicare Rebate Suit
- Zoll Hits Philips With Patent Suit Over Defibrillators
- MedIdea Seeks Rehearing Of Patent Suit Transfer
- Polio Vaccine Suit Against Pfizer, Others Dismissed
- FTC Demands More Info On $1.6B Charles River Deal
- Confusion Abounds For Big Pharma After EU Astra Ruling
- Calif. High Court Nixes 'Pass-On' Defense
- Apotex Eyes Generic Version Of Cephalon's Nuvigil
- Sabinsa Wins Mint Extract Trademark Spat In 3rd Circ.
- FocusFactor Distributors Falsely Marked Product: Suit
- CB Fleet Settles Bowel Cleanser Product Liability MDL
- Medtronic Faces False Marking Suit Over Stents
- Ciphergen Patent Licensing Spat Sent To Arbitration
- McDermott Snags Former FDA Bigwig From Buchanan
- Genzyme Sues Watson Over Renvela Powder ANDA
- Pharmacy Benefit Manager Law Preempted: DC Circ.
- Caliper Life Sued Over Animal Imaging Patent
- Cravath, Weil Advise J&J On $480M Micrus Purchase
- Consumers Target J&J Over Children's Drug Recalls
- Siemens Fights For Patent Priority On DNA Method
- 2nd Circ. Novartis Ruling Muddies Sales Rep OT Issue
- WellCare Directors Dismissed From Derivative Suit
- Russian Antitrust Watchdog Targets Novo Nordisk
- FDA Doctor Calls GSK Avandia Trial Biased
- Latham, Simpson Handle $3B MultiPlan Acquisition
- Fosamax Victor's Lawyer Faces Sanctions For Closing
- Gilead To Pay $8M To Settle Viread Securities Action
- Do You Really Want Grandfathered Health Plan Status?
- Claims Trimmed In Suit Over Amacore-Lifeguard Deal
- J&J Expands OTC Drug Recall Over Smell Issue
- Farella Braun Reps The Doctors Co. In $386M Deal
- Medical Groups Seek Action On Device Tracking Rule
- AMS, Laser Peripherals Settle Patent Dispute
- Alcon Forms $50M Trust For Novartis Shareholder Suits
- Shire Slaps Zydus With Suit Over Lialda ANDA
- Talecris Settles Jilted Job-Seeker FCRA Class Action
- Rx USA Hit With Sanctions Over Faked E-Mails
- Genzyme Fights To Keep Anika's Monovisc Out Of US
- Injunction On Apotex Reinstated In Fortical IP Suit
- Merck, Sanofi Vaccine Deals Could Face FTC Probe
- ALC, GN Add Fuel To Hearing Aid Patent Battle
- Aspen Lowers Offer For Sigma To $552M
- Ev3 Inc. Settles Suits Over $2.6B Covidien Merger
- Obama Installs Medicare Chief With Recess Pick
- Skilled Healthcare Hit With $671M Verdict
- Novartis Challenges USPTO Patent Extension Policy
- Schering Settles With Supplier Over Recall Costs
- Argentum Claims Nixed In Wound Dressing Patent Suit
- Senate Panel Probes $60M In Missing Medicare Claims
- 11th Circ. Revives Doctors' United Healthgroup Claims
- FDA Warns Cornerstone Over Zyflo Marketing
- 9th Circ. Affirms Dismissal Of Cutera Investor Suit
- Amedisys Gamed Medicare System, Shareholders Say
- FDA Issues Class I Recall Of Medtronic Defibrillators
- Polish Health Attys Jump To Baker & McKenzie
- Dentist Bites Nobel Biocare With Faulty Implant Action
- WilmerHale Snags Wyeth Bigwig For IP Team
- EU Report Shows Drop In Pay-For-Delay Deals
- Odyssey Shareholders Sue Over $1B Gentiva Merger
- Mass. Hospitals Pare Parallel Worker Class Actions
- Temp Nursing Giant MSN To Sell Assets To Creditors
- 2nd Circ. Finds Drug Reps Not Exempt From FLSA
- $44M Verdict Sticks In Dentsply Contract Spat
- Latham & Watkins Reps Eli Lilly In Alnara Acquisition
- Actavis, Sandoz Open Fire On Prandin Patent
- Wyeth Sues IPC To Stave Off Effexor Generic Bid
- Genzyme Sues Impax Over Generic Renvela Powder
- The Power Of Procedure Under Anti-SLAPP Laws
- House Slips Pay-For-Delay Ban Into War Bill
- Ex-PDL Exec Can't Dodge MedImmune Subpoena
- Glenmark Slapped With Sanctions In Tarka ANDA Suit
- Wal-Mart Medical Treatment Class Action Proceeds
- Drug Giants Face Congressional FCA Inquiry
- Enzo DNA Patent Suits Remain On Hold For High Court
- AsymmetRx Ends Cancer Test IP Suit Against Dako
- EU Court Backs Astra Antitrust Fine Over Patent Abuse
- Mannatech Rivals To Halt Sale Of Dietary Supplements
- What Must An Inventor Do To Possess An Invention?